Vera da Ros (Rede Brasileira de Redução de Danos e Direitos Humanos - REDUC)
17 July 2014
The IV Symposium on Medicinal Cannabis in Brazil focused on patients who need treatment via medicinal cannabis and its components. Today, these patients struggle with access to such treatment, mainly due to bureaucracy. The event undoubtedly generated attitudes in favor of medical marijuana in the country. However, and unfortunately, less than 10 days after the event ended, National Health Surveillance Agency (ANVISA) postponed a vote for the reclassification of cannabis.
The nation's top medical organization released a major series of papers on medical cannabis last week in the Journal of the American Medical Association, in a move that constitutes a small step for the AMA, but a giant leap in cannabis medical history.
Eliseu Labigalini Jr, Lucio Ribeiro Rodrigues, Dartiu Xavier Da Silveira
01 October 1999
This study ensued from clinical observations based on spontaneous accounts by crack abusers undergoing their first psychiatric assessment, where they reported using cannabis in an attempt to ease their own withdrawal symptoms.
Pien Metaal, who follows Latin American drug law reform ... told The Tico Times ... that legalizing medical marijuana in Costa Rica “would clearly send a message that can spark a debate in the region... Of course, the debate should not just be about medicinal use,” Metaal wrote, “since in fact recreational use is the largest actually existing phenomena, [for] which simple possession and use are being criminalized and prosecuted.”
In a decision that could have immediate fallout for medical marijuana dispensaries, a state appeals court has ruled that California law allows cities and counties to ban the stores. The contentious issue has bounced through the state courts for years, but the opinion issued Wednesday is the first published one that directly tackles it and does so in unambiguous language. The decision could embolden more cities and counties to enact their own. It also could spur those that have bans to be more aggressive about seeking court orders to close defiant dispensaries.
Several members of California's congressional delegation are taking their concerns about a federal crackdown on the state's medical marijuana dispensaries directly to President Barack Obama. In a bipartisan letter signed by nine members of the U.S. House of Representatives, the lawmakers criticized what they called an "unconscionable" multi-state effort targeting medical marijuana dispensaries. They also called for the reclassification of marijuana as a controlled substance subject to fewer federal restrictions.
Drug law reform continues developing in the right direction in several Latin American and Caribbean countries. In Jamaica, for example, a law legalizing the cultivation and consumption of ganja for medicinal, religious and research purposes came into force, as well as the decriminalisation of possession for personal use. Jamaica also spoke out at the UN Thematic Debate in New York. On May 7th, the minister addressed the UN High Level Thematic Debate on international drug policy, highlighting Jamaica’s perspectives on drug control policies and participating in a debate that encourages open and inclusive discussions. Amongst the outcomes Jamaica would like to see from UNGASS is “the establishment of an Expert Advisory Group to review the UN drug policy control architecture, its system-wide coherence, its treaty inconsistencies and its legal tension with cannabis regulations.”
Tens of thousands of people will attend Saturday's "4/20" rally in Denver, creating perhaps the largest collectively produced cloud of marijuana smoke ever at 4:20 p.m. But Lopez doesn't view this year's event as a celebration of Amendment 64, the pro-pot measure that voters passed in November. Instead, it is as much a protest against the measure. "It is still only a legislative act to create an economy and not to end a war that has destroyed thousands of lives." The people behind Amendment 64, likewise, are holding the rally at arm's length.
In July 2016, the Colombian government enacted Law 1787, which regulates the use of medicinal cannabis and its trade in the country. With this decision and a series of subsequent resolutions, Colombia joined the more than a dozen countries that have put into practice different types of regulation to explore the advantages of this plant as an alternative pharmaceutical.
The 43-year-old war on drugs had never seen such a barrage of opposition as it did in 2014, with successful marijuana legalization initiatives in several U.S. states, California’s historic approval of sentencing reform for low level drug offenders and world leaders calling for the legal regulation of all drugs — all of which cement the mainstream appeal of drug policy alternatives and offer unprecedented momentum going into 2015.
The vaping trend seemingly knows no bounds as the first “cannabis” e-cigarette goes on sale in the UK. The KanaVape, which contains hemp, has been legalised for use in France by people with cancer, multiple sclerosis (MS) and other conditions requiring pain relief. It will go on sale around the world tomorrow but the Home Office has cast doubt on whether that would be legal, saying the product must be tested for controlled substances. KanaVape cannot be compared to a joint because it does not contain THC, the chemical causing cannabis highs.
The organisers of a Czech petition for the legalisation of cannabis in medical treatment have asked Prime Minister Petr Necas to support the relevant changes in legislation. The petition committee, including doctors, patients and scientists, recalls that it does not seek the legalisation of marijuana for recreational use. Since its launch on August 16, the petition has been signed by almost 5,000 people.
The Czech Republic already has one of the world’s most liberal approach to recreational drug possession. And it will get more liberal still: beginning next year the government will allow marijuana to be distributed by pharmacies for patients with a prescription. Lawmakers in parliament’s lower house overwhelmingly passed a bill clearing the way for legal, but regulated medical marijuana on December 7.
A group of medical and criminal law experts are moving forward with drafting a plan that would clear marijuana for medicinal use. "There is a consensus between parties in the coalition and with the opposition that making marijuana legal for medical purposes is a good thing," said National Anti-Drug Coordinator Jindřich Vobořil, deputy chairman of the committee drafting the proposal.
More than 10,000 patients who have official government permission consume marijuana in Israel, a number that has swelled dramatically, up from serving just a few hundred patients in 2005. The medical cannabis industry is expanding as well, fuelled by Israel’s strong research sector in medicine and technology – and notably, by government encouragement. Unlike in the United States and much of Europe, the issue inspires almost no controversy among the government and the country’s leadership.
History is expected to be created next week when Jamaica's first medical marijuana company, which is intended to be instrumental in extracting the medicinal value from the addictive elements of ganja, comes into being. Internationally renowned Jamaican scientist Professor Henry Lowe, the brainchild behind the initiative, has high hopes for the use of medical marijuana in Jamaica.
Even though, in 1998, the Home Office granted GW Pharmaceuticals a license to grow cannabis in order to develop cannabinoid-based medicines, Britain is not following suit. Norman Baker, Lib Dem minister of state for crime prevention, called for more liberalised drug laws, and specifically the legalisation of cannabis grown for medicinal use. A coalition spokesman rejected his suggestion outright. And so those seeking cannabis for medicinal purposes must continue to chase it in the same way as recreational users, through the black market.
Executive Chairman of Medicanja, Dr Henry Lowe, is urging a spirit of cooperation between government ministries and agencies involved in the development of Jamaica's ganja industry, following the passage of the Decriminalisation Bill.